Safety and Tolerability of Coenzyme Q10 in Hemodialysis Patients

Completed · Not applicable

Conditions studied: Cardiovascular Disease, End Stage Renal Disease, Atherosclerosis, Oxidative Stress

In brief

The purpose of this study is to determine the safety and tolerability of the dietary supplement Coenzyme Q10 in hemodialysis patients.

Key facts

Study ID
NCT00908297
Run by
University of Washington
People needed
20
Starts
2010-02-01
Expected to finish
2010-11-01
Last updated by the study team
2012-04-24

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.